Description

Do you struggle with symptoms of depression? You may be able to take part in a research study. Some people experience decreased motivation, trouble finding enjoyment in everyday activities, and difficulty with sleep because of their depression. These challenges—known as symptoms of depression—can significantly affect daily life and overall well-being. Unfortunately, the medications available don’t always fully relieve these symptoms. The OARS-7 Study is examining a new investigational medication added on to your current treatment to potentially provide additional support for individuals struggling with motivation and enjoyment and insomnia due to depression. What is the OARS-7 Study? The OARS-7 study is two parts. If you are eligible to take part in the study, you have the option to complete both parts. The first part is a randomized control trial of the study medication versus a placebo. The second part is an open label treatment phase for study medication and a second subsequent randomized control trial for study medication versus placebo. The results of this study could help other people who experience symptoms of depression and need additional support. Who can take part? You may qualify for the OARS-7 Study if you are: • Between the ages of 18-74 • Have a primary diagnosis of Major Depressive Disorder (MDD) • Have been on a stable dose of an antidepressant medication (SSRI/SNRI) • Are still experiencing symptoms of depression This research study is completely voluntary. If you qualify, you do not have to join the study, and if you do join, you can leave the study at any time. Interested? Contact us at: 312-503-7071 https://sites.northwestern.edu/mindtrials/research/current-trials-for-depression/ Principal Investigator: Jeffrey Rado, MD STU00223008